HANSOH PHARMA(03692),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

03692 HANSOH PHARMA

Closed 06-11 16:08:30

29.220

-0.080

-0.27%

High29.700	Low28.900	Vol11.23M
Open29.300	D1 Closing29.300	Amplitude2.73%
Mkt Cap177.19B	Tradable Cap177.19B	Total Shares6.06B
T/O327.42M	T/O Rate0.19%	Tradable Shares6.06B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"03692","market":"HK","secType":"STK","nameCN":"HANSOH PHARMA","latestPrice":29.22,"timestamp":1781165310005,"preClose":29.3,"halted":0,"volume":11227854,"delay":0,"changeRate":-0.0027303754266212233,"floatShares":6064000000,"shares":6064000000,"eps":0.93,"marketStatus":"Closed","change":-0.08,"latestTime":"06-11 16:08:30","open":29.3,"high":29.7,"low":28.9,"amount":327420522,"amplitude":0.027304,"askPrice":29.24,"askSize":46000,"bidPrice":29.16,"bidSize":42000,"shortable":3,"etf":0,"ttmEps":1.033788,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1781227800000},"marketStatusCode":5,"adr":0,"listingDate":1560441600000,"exchange":"SEHK","adjPreClose":29.3,"dividendRate":0.015012,"openAndCloseTimeList":[[1781141400000,1781150400000],[1781154000000,1781164800000]],"volumeRatio":0.938267,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03692","defaultTab":"news","newsList":[{"id":"2642752064","title":"Hansoh Pharmaceutical Group (SEHK:3692) Valuation Check After Hang Seng China Enterprises Index Inclusion","url":"https://stock-news.laohu8.com/highlight/detail?id=2642752064","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642752064?lang=en_us&edition=fundamental","pubTime":"2026-06-11 01:18","pubTimestamp":1781111934,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical Group added to Hang Seng China Enterprises Index\nHansoh Pharmaceutical Group (SEHK:3692) has been added to the Hang Seng China Enterprises Index, a move that increases the stock’s visibility and may influence flows from index-linked funds.\nSee our latest analysis for Hansoh Pharmaceutical Group.\nAlongside the index inclusion, Hansoh Pharmaceutical Group’s share price has been under pressure recently. It has a 30 day share price return of down 20.12% and a year to date...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3692/hansoh-pharmaceutical-group-shares/news/hansoh-pharmaceutical-group-sehk3692-valuation-check-after-h","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3692/hansoh-pharmaceutical-group-shares/news/hansoh-pharmaceutical-group-sehk3692-valuation-check-after-h","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1191","BK1583","BK1589","03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191405798","title":"Hansoh Pharma Appoints Guo Ying as Joint Company Secretary Following Zhong Shengli’s Resignation","url":"https://stock-news.laohu8.com/highlight/detail?id=1191405798","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191405798?lang=en_us&edition=fundamental","pubTime":"2026-06-10 18:45","pubTimestamp":1781088303,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical Group Company Limited (Hansoh Pharma) has announced a leadership change within its corporate governance team. Effective 10 June 2026, Zhong Shengli has resigned as joint company...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185744156","title":"Hansoh Pharma’s NDA for HS-10568 Injection Accepted by China’s NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=1185744156","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185744156?lang=en_us&edition=fundamental","pubTime":"2026-06-10 18:44","pubTimestamp":1781088297,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical Group Company Limited (Hansoh Pharma) disclosed that the National Medical Products Administration (NMPA) formally accepted the New Drug Application (NDA) for HS-10568 Injection...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141642657","title":"HANSOH PHARMA Receives NMPA Acceptance for New Drug Application of HS-10568 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1141642657","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141642657?lang=en_us&edition=fundamental","pubTime":"2026-06-10 18:44","pubTimestamp":1781088290,"startTime":"0","endTime":"0","summary":"HANSOH PHARMA (03692) has announced that the New Drug Application for its innovative product, HS-10568 injection, has been accepted for review by China's National Medical Products Administration.The...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","BK1589","03692","BK1191","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642440459","title":"Hansoh Pharma says China regulator accepts NDA for HS-10568 injection in kidney disease complication","url":"https://stock-news.laohu8.com/highlight/detail?id=2642440459","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642440459?lang=en_us&edition=fundamental","pubTime":"2026-06-10 18:41","pubTimestamp":1781088065,"startTime":"0","endTime":"0","summary":"The filing was accepted on June 9, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hansoh Pharmaceutical Group Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on June 10, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nNDL2Ww8WJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","BK1191","03692","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642440480","title":"Hansoh Pharmaceutical - Nda for Hs-10,568 Injection Accepted by Nmpa of China for Shpt in Adult Ckd Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2642440480","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642440480?lang=en_us&edition=fundamental","pubTime":"2026-06-10 18:40","pubTimestamp":1781088044,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nFWN42I07G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","03692","BK1589","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175489429","title":"HANSOH PHARMA Announces Appointment of Guo Ying as Joint Company Secretary","url":"https://stock-news.laohu8.com/highlight/detail?id=1175489429","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175489429?lang=en_us&edition=fundamental","pubTime":"2026-06-10 18:34","pubTimestamp":1781087696,"startTime":"0","endTime":"0","summary":"HANSOH PHARMA (03692) has announced a change in its company secretarial team. Ms. Zhong Shengli has resigned from her position as a Joint Company Secretary of the company, effective June 10, 2026....","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1589","03692","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642144950","title":"Hansoh Pharmaceutical Group  Stock Rises 2.6% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2642144950","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642144950?lang=en_us&edition=fundamental","pubTime":"2026-06-10 16:33","pubTimestamp":1781080380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Hansoh Pharmaceutical Group Co. Ltd. rose 2.6% to 29.30 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.6% to 24407.96.The stock's rise snapped a seven-day losing streak.Hansoh Pharmaceutical Group Co. Ltd. closed 34% short of its 52-week high of HK$44.22, which the company reached Jan. 15.Trading volume totaled 7.8 million shares, compared to the 50-day average of 10.7 million shares.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1589","03692","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641022961","title":"Hansoh Pharmaceutical Group  Stock Falls 1.8% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2641022961","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641022961?lang=en_us&edition=fundamental","pubTime":"2026-06-08 16:32","pubTimestamp":1780907520,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Hansoh Pharmaceutical Group Co. Ltd. slipped 1.8% to 28.78 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.2% to 24657.06.This was the stock's sixth consecutive day of losses.Hansoh Pharmaceutical Group Co. Ltd. closed 35% below its 52-week high of HK$44.22, which the company achieved Jan. 15.Trading volume totaled 12.9 million shares, compared to the 50-day average of 10.8 million shares.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1589","BK1191","03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641115124","title":"Hansoh Pharmaceutical Group  Stock Sheds 1.6% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2641115124","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641115124?lang=en_us&edition=fundamental","pubTime":"2026-06-05 16:32","pubTimestamp":1780648320,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Hansoh Pharmaceutical Group Co. Ltd. slipped 1.6% to 29.32 Hong Kong dollars on what proved to be an all-around rough trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.2% to 24961.95.This was the stock's fifth consecutive day of losses.Hansoh Pharmaceutical Group Co. Ltd. closed 34% short of its 52-week high of HK$44.22, which the company achieved Jan. 15.Trading volume totaled 20.9 million shares, compared to the 50-day average of 10.5 million shares.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1583","03692","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122076064","title":"HANSOH PHARMA Shares Surge on New Drug Application Acceptance","url":"https://stock-news.laohu8.com/highlight/detail?id=1122076064","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122076064?lang=en_us&edition=fundamental","pubTime":"2026-06-05 09:28","pubTimestamp":1780622898,"startTime":"0","endTime":"0","summary":"Shares of HANSOH PHARMA (HKEX: 03692) opened notably higher, gaining over 2%. At the time of writing, the stock is up 2.08%, trading at HK$30.42 with a turnover of HK$16.4 million.The upward movement...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692","159992","BK1574","BK4585","BK4588","06978","VXUS","BK1161","BK1583","BK1589","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640154394","title":"Hansoh Pharma seeks shareholder approval for 2026 share option and award scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=2640154394","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640154394?lang=en_us&edition=fundamental","pubTime":"2026-06-04 19:06","pubTimestamp":1780571192,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical will seek shareholder approval on June 26, 2026 to adopt its 2026 Share Scheme.The plan authorizes grants of share options and share awards.The board would be empowered to issue shares for option or award exercises, buy shares in the open market, appoint trustees, amend the scheme.Separate votes would adopt a scheme mandate limit, with an additional service provider sublimit.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hansoh Pharmaceutical Group Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on June 04, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDL70JH9q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1191","03692","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640151079","title":"Hansoh Pharma announces annual general meeting notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2640151079","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640151079?lang=en_us&edition=fundamental","pubTime":"2026-06-04 19:03","pubTimestamp":1780570996,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical will hold its annual general meeting in Hong Kong on June 26, 2026.Shareholders will vote on director re-elections, including Zhong Huijuan, Yang Dongtao, and Yan Jia.Resolutions also cover mandates to repurchase up to 606,415,007 shares and issue up to 1,212,830,014 shares.The meeting will consider a final dividend of HK$ 0.2 per share for the year ended Dec. 31, 2025.Other items include reappointing Ernst & Young as auditor and adopting the 2026 share scheme with a 121,283,001-share limit.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hansoh Pharmaceutical Group Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exch","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDLccFcpf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1191","BK1589","03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640135416","title":"Hansoh Pharmaceutical's Weight-loss Injection Enters China Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2640135416","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640135416?lang=en_us&edition=fundamental","pubTime":"2026-06-04 10:03","pubTimestamp":1780538581,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical  said China's National Medical Products Administration accepted its application of olatorepatide injection to treat obesity, according to a Thursday filing with the Hong Kong bourse.The drug is meant to be administered once a week.Shares of the company fell nearly 1% in recent morning trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["03692","BK1583","BK1191","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640809561","title":"BRIEF-Hansoh Pharmaceutical Says NDA For Olatorepatide Injection Accepted By China's NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2640809561","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640809561?lang=en_us&edition=fundamental","pubTime":"2026-06-04 07:49","pubTimestamp":1780530546,"startTime":"0","endTime":"0","summary":"BRIEF-Hansoh Pharmaceutical Says NDA For Olatorepatide Injection Accepted By China's NMPAJune 4  - Hansoh Pharmaceutical Group Company Ltd 3692.HK:NDA FOR OLATOREPATIDE INJECTION ACCEPTED BY NMPA OF CHINA FOR CHRONIC WEIGHT MANAGEMENTFurther company coverage: 3692.HK ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nFWN42B0Y7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","BK1583","BK1191","03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138975652","title":"HANSOH PHARMA's Obesity Drug Application Accepted by Chinese Regulator","url":"https://stock-news.laohu8.com/highlight/detail?id=1138975652","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138975652?lang=en_us&edition=fundamental","pubTime":"2026-06-04 07:42","pubTimestamp":1780530134,"startTime":"0","endTime":"0","summary":"HANSOH PHARMA (03692) has announced that the New Drug Application for its innovative product, the Olepeptide Injection, has been accepted for review by China's National Medical Products...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692","BK1191","BK1589","IPOS","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640180373","title":"Hansoh Pharma says China regulator accepts NDA for olatorepatide weight management injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2640180373","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640180373?lang=en_us&edition=fundamental","pubTime":"2026-06-04 07:30","pubTimestamp":1780529445,"startTime":"0","endTime":"0","summary":"China’s NMPA accepted Hansoh Pharmaceutical’s NDA for Olatorepatide Injection for chronic weight management in obese or overweight adults.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hansoh Pharmaceutical Group Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on June 03, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL3y5cMT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","03692","BK1583","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640180324","title":"Hansoh Pharmaceutical - Nda for Olatorepatide Injection Accepted by Nmpa of China for Chronic Weight Management","url":"https://stock-news.laohu8.com/highlight/detail?id=2640180324","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640180324?lang=en_us&edition=fundamental","pubTime":"2026-06-04 07:30","pubTimestamp":1780529437,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nFWN42B0Y7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","03692","BK1191","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640497271","title":"Hansoh Pharmaceutical Group  Stock Sheds 2.3% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2640497271","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640497271?lang=en_us&edition=fundamental","pubTime":"2026-06-03 16:32","pubTimestamp":1780475520,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Hansoh Pharmaceutical Group Co. Ltd. slipped 2.3% to 30.30 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.6% to 25633.21.This was the stock's third consecutive day of losses.Hansoh Pharmaceutical Group Co. Ltd. closed 31% below its 52-week high of HK$44.22, which the company achieved Jan. 15.Trading volume totaled 12.2 million shares, compared to the 50-day average of 10.3 million shares.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1191","03692","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638651896","title":"Hansoh Pharmaceutical Group  Stock Sheds 7.1% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2638651896","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638651896?lang=en_us&edition=fundamental","pubTime":"2026-05-28 16:30","pubTimestamp":1779957000,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Hansoh Pharmaceutical Group Co. Ltd. slid 7.1% to 31.40 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.3% to 25006.16.This was the stock's second consecutive day of losses.Hansoh Pharmaceutical Group Co. Ltd. closed 29% below its 52-week high of HK$44.22, which the company achieved Jan. 15.Trading volume totaled 13.3 million shares, compared to the 50-day average of 9.5 million shares.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","03692","BK1191","BK1589"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.033},{"period":"1month","weight":-0.2012},{"period":"3month","weight":-0.1259},{"period":"6month","weight":-0.3186},{"period":"1year","weight":0.027},{"period":"ytd","weight":-0.1879}],"compareEarnings":[{"period":"1week","weight":-0.0478},{"period":"1month","weight":-0.0757},{"period":"3month","weight":-0.0509},{"period":"6month","weight":-0.0604},{"period":"1year","weight":0.0101},{"period":"ytd","weight":-0.0477}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Hansoh Pharmaceutical Group Company Ltd is an investment holding company primarily engaged in the research and development, production and sale of a series of pharmaceutical products. The Company’s innovative drug products include Ameile, Hansoh Xinfu, Mailingda, Fulaimei, Hengmu, XINYUE, Saint Luolai and other products. The Company’s drug products are mainly used in oncology, anti-infective diseases, central nervous system (CNS) diseases, metabolic diseases and other therapeutic areas. The Company mainly conducts its business in the domestic market.","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":-0.002565},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.01282},{"month":3,"riseRate":0.428571,"avgChangeRate":0.023369},{"month":4,"riseRate":0.571429,"avgChangeRate":0.03396},{"month":5,"riseRate":0.571429,"avgChangeRate":-0.00521},{"month":6,"riseRate":0.571429,"avgChangeRate":0.037952},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.000332},{"month":8,"riseRate":0.714286,"avgChangeRate":0.01897},{"month":9,"riseRate":0.571429,"avgChangeRate":-0.033021},{"month":10,"riseRate":0.142857,"avgChangeRate":0.001586},{"month":11,"riseRate":0.714286,"avgChangeRate":0.063467},{"month":12,"riseRate":0.571429,"avgChangeRate":0.016858}],"exchange":"SEHK","name":"HANSOH PHARMA","nameEN":"HANSOH PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"HANSOH PHARMA(03692),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest HANSOH PHARMA(03692) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"HANSOH PHARMA,03692,HANSOH PHARMA股票,HANSOH PHARMA股票老虎,HANSOH PHARMA股票老虎国际,HANSOH PHARMA行情,HANSOH PHARMA股票行情,HANSOH PHARMA股价,HANSOH PHARMA股市,HANSOH PHARMA股票价格,HANSOH PHARMA股票交易,HANSOH PHARMA股票购买,HANSOH PHARMA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"HANSOH PHARMA(03692),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest HANSOH PHARMA(03692) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}